Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Radiate brilliantly: The 5 Precious stone Rings to Purchase in 2024 - 2Wedding trip Objections in Europe
- 3Protest inspired by 'Gen Z' movement draws few young people in Mexico and many government critics
- 4Kelsey Grammer on having a new baby at 70: 'You're just more available now'
- 5Defeating An inability to embrace success in Scholarly world: Individual Victories
- Bruno Mars tour 2026: How to get tickets for 'The Romantic Tour,' presale times, prices and more
- Virtual Route d: A Survey of \Exploring On the web Stages\ Web Administration
- Well known Worldwide Caf\u00e9s to Experience
- Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers
- The most effective method to Amplify Profits from Gold Speculation: Systems and Tips
- Putin, Netanyahu discuss Middle East in phone call, Kremlin says
- The newest 'Project Hail Mary' trailer shows Ryan Gosling befriending an alien in Phil Lord and Chris Miller's space epic
- Instructions to Construct an Organization While Chasing after a Web-based Degree
- Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
